These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19925484)

  • 1. Failure of omalizumab in cholinergic urticaria.
    Sabroe RA
    Clin Exp Dermatol; 2010 Jun; 35(4):e127-9. PubMed ID: 19925484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria.
    Metz M; Altrichter S; Ardelean E; Kessler B; Krause K; Magerl M; Siebenhaar F; Weller K; Zuberbier T; Maurer M
    Int Arch Allergy Immunol; 2011; 154(2):177-80. PubMed ID: 20733327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
    Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
    J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of omalizumab on patients with chronic urticaria.
    Spector SL; Tan RA
    Ann Allergy Asthma Immunol; 2007 Aug; 99(2):190-3. PubMed ID: 17718108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic autoimmune urticaria: treatment with omalizumab].
    Máspero JF; Parisi CA; De Gennaro M; Benhabib O; Lampert M
    Arch Argent Pediatr; 2009 Oct; 107(5):452-6. PubMed ID: 19809768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy.
    Metz M; Bergmann P; Zuberbier T; Maurer M
    Allergy; 2008 Feb; 63(2):247-9. PubMed ID: 18186820
    [No Abstract]   [Full Text] [Related]  

  • 8. Omalizumab also successful in chronic urticaria.
    Spector SL; Tan RA
    J Allergy Clin Immunol; 2008 Mar; 121(3):784; author reply 784-5. PubMed ID: 18328900
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial improvement of solar urticaria after omalizumab.
    Waibel KH; Reese DA; Hamilton RG; Devillez RL
    J Allergy Clin Immunol; 2010 Feb; 125(2):490-1. PubMed ID: 20159260
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of omalizumab on patients with chronic urticaria: issues with the determination of autoimmune urticaria.
    Sheikh J
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):88; author reply 88-9. PubMed ID: 18254490
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective treatment of refractory severe heat urticaria with omalizumab.
    Bullerkotte U; Wieczorek D; Kapp A; Wedi B
    Allergy; 2010 Jul; 65(7):931-2. PubMed ID: 19930230
    [No Abstract]   [Full Text] [Related]  

  • 12. Omalizumab in chronic urticaria.
    Metz M; Maurer M
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic alternatives for chronic urticaria: additional reports on omalizumab.
    Spector SL; Tan RA
    Ann Allergy Asthma Immunol; 2008 Dec; 101(6):647. PubMed ID: 19119713
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.
    Magerl M; Staubach P; Altrichter S; Ardelean E; Krause K; Metz M; Weller K; Maurer M
    J Allergy Clin Immunol; 2010 Sep; 126(3):665-6. PubMed ID: 20673981
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological effects of omalizumab in chronic urticaria: a case report.
    Iemoli E; Piconi S; Fusi A; Borgonovo L; Borelli M; Trabattoni D
    J Investig Allergol Clin Immunol; 2010; 20(3):252-4. PubMed ID: 20635791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab in chronic urticaria: a retrospective series of 15 cases.
    Armengot-Carbo M; Velasco-Pastor M; Rodrigo-Nicolas B; Pont-Sanjuan V; Quecedo-Estebanez E; Gimeno-Carpio E
    Dermatol Ther; 2013; 26(3):257-9. PubMed ID: 23742285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of omalizumab in delayed pressure urticaria: a case report.
    Bindslev-Jensen C; Skov PS
    Allergy; 2010 Jan; 65(1):138-9. PubMed ID: 19804440
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light.
    Duchini G; Bäumler W; Bircher AJ; Scherer K
    Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):336-7. PubMed ID: 22092741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab as a therapeutic alternative for chronic urticaria.
    Callejas-Rubio JL; Sánchez-Cano D; Lara MA; Ortego-Centeno N
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):556. PubMed ID: 19055216
    [No Abstract]   [Full Text] [Related]  

  • 20. Omalizumab is effective in nonautoimmune urticaria.
    Ferrer M; Gamboa P; Sanz ML; Goikoetxea MJ; Cabrera-Freitag P; Javaloyes G; Berroa F; Kaplan AP
    J Allergy Clin Immunol; 2011 May; 127(5):1300-2. PubMed ID: 21315432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.